URENIDY Trademark

Trademark Overview

On Wednesday, March 20, 2019, a trademark application was filed for URENIDY with the United States Patent and Trademark Office. The USPTO has given the URENIDY trademark a serial number of 79259157. The federal status of this trademark filing is REGISTERED as of Tuesday, November 26, 2019. This trademark is owned by Urovant Sciences GmbH. The URENIDY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the prevention of urological, urinary tract systems, and reproductive organ diseases and disorders; Pharmaceutical preparations for human use for the treatment of urological, urinary tract systems, and reproductive organ diseases and disorders; Biological and pharmaceutical preparations for medical and therapeutic use for the prevention of urological, urinary tract systems, and reproductive organ diseases and disorders; Biological and pharmaceutical preparations for medical and therapeutic use for the treatment of urological, urinary tract systems, and reproductive organ diseases and disorders; Pharmaceutical preparations for treatment of bladder and urinary conditions; Pharmaceutical preparations for treatment of overactive bladder
urenidy

General Information

Serial Number79259157
Word MarkURENIDY
Filing DateWednesday, March 20, 2019
Status700 - REGISTERED
Status DateTuesday, November 26, 2019
Registration Number5917424
Registration DateTuesday, November 26, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 10, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the prevention of urological, urinary tract systems, and reproductive organ diseases and disorders; Pharmaceutical preparations for human use for the treatment of urological, urinary tract systems, and reproductive organ diseases and disorders; Biological and pharmaceutical preparations for medical and therapeutic use for the prevention of urological, urinary tract systems, and reproductive organ diseases and disorders; Biological and pharmaceutical preparations for medical and therapeutic use for the treatment of urological, urinary tract systems, and reproductive organ diseases and disorders; Pharmaceutical preparations for treatment of bladder and urinary conditions; Pharmaceutical preparations for treatment of overactive bladder

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 28, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameUrovant Sciences GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressCH
Party NameUrovant Sciences GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressCH
Party NameUrovant Sciences GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Friday, April 12, 2024WITHDRAWAL OF ATTORNEY GRANTED
Friday, April 12, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Monday, April 8, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 8, 2024TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Monday, April 8, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 8, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 8, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 8, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 23, 2024NEW REPRESENTATIVE AT IB RECEIVED
Saturday, March 18, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, November 25, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, April 29, 2022NEW REPRESENTATIVE AT IB RECEIVED
Monday, March 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 28, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, March 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 3, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, March 14, 2020FINAL DISPOSITION NOTICE SENT TO IB
Saturday, March 14, 2020FINAL DISPOSITION PROCESSED
Wednesday, February 26, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 26, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, September 10, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 10, 2019PUBLISHED FOR OPPOSITION
Wednesday, August 21, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 30, 2019WITHDRAWN FROM PUB - OG REVIEW QUERY
Saturday, July 27, 2019REFUSAL PROCESSED BY IB
Friday, July 26, 2019NEW REPRESENTATIVE AT IB RECEIVED
Monday, July 15, 2019ASSIGNED TO LIE
Monday, July 8, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 26, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 25, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 25, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, June 22, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, June 22, 2019REFUSAL PROCESSED BY MPU
Saturday, June 1, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, June 1, 2019APPLICATION FILING RECEIPT MAILED
Friday, May 31, 2019NON-FINAL ACTION WRITTEN
Thursday, May 30, 2019ASSIGNED TO EXAMINER
Tuesday, May 28, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 23, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

urenidy pharmaceutical preparations urinary diseases disorders treatment reproductive organ systems urological